Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tapentadol PR dose escalation versus tapentadol PR + pregabalin for severe chronic low back pain with neuropathic component
2010-019998-14Phase 3Completed
- Sponsor
- Grünenthal GmbH
- Start
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in chronic low back pain (CLBP) and Neuralgia comparing Tapentadol PR dose escalation with Tapentadol PR + pregabalin (2 arms). Primary endpoint: Primary efficacy endpoint. Started Dec 2010; status: completed.
02
Drugs
tapentadolpregabalin
03
Conditions
chronic low back pain (CLBP)Neuralgia
Beyond the preview
Go deeper on 2010-019998-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019998-14.